You are here

epcoritamab

AbbVie and Genmab report data from follicular lymphoma antibody trial

Clinical Trials Arena

Mon, 12/11/23 - 09:59 am

clinical trials

bispecific antibodies

relapsed or refractory follicular lymphoma

AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug

BioSpace

Thu, 06/29/23 - 11:15 pm

follicular lymphoma

bispecific antibodies

AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race

Fierce Pharma

Sun, 05/21/23 - 07:46 pm

diffuse large B-cell lymphoma

AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday

Fierce Biotech

Mon, 11/21/22 - 10:12 am

bispecific antibodies

relapsed or refractory large B-cell lymphoma

AbbVie & Genmab EHA Data Indicate LBCL Drug Could Fill Unmet Need

BioSpace

Mon, 06/13/22 - 09:51 pm

clinical trials

AbbVie preps filings for lymphoma bispecific licensed from Genmab

Pharmaforum

Thu, 04/14/22 - 10:39 am

large B-cell lymphoma

AbbVie to pay Genmab $750M upfront to form bispecific R&D pact

Fierce Biotech

Wed, 06/10/20 - 11:01 am

bispecific antibodies